Skip to main content
Livermore
Livermore
ZHEN

Aspiriant, LLC

SEC CIK
0001433541
Latest filing
Jul 20, 2026

GS holding history

Goldman Sachs Group Inc in every 13F filed by Aspiriant, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GS overviewAll 13F holders of GSFull Q2 2026 holdings

Shares (Q2 2026)
1,214
Value
$1.23M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GS by Aspiriant, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,214$1.23M<0.1%+228+23.1%AddedHolders
Q1 2026986$834.1K<0.1%−12−1.2%ReducedHolders
Q4 2025998$877.2K<0.1%+122+13.9%AddedHolders
Q3 2025876$697.6K<0.1%−127−12.7%ReducedHolders
Q2 20251,003$709.9K<0.1%−22−2.1%ReducedHolders
Q1 20251,025$559.9K<0.1%+44+4.5%AddedHolders
Q4 2024981$561.7K<0.1%+54+5.8%AddedHolders
Q3 2024927$459.0K<0.1%−447−32.5%ReducedHolders
Q2 20241,374$621.5K<0.1%−413−23.1%ReducedHolders
Q1 20241,787$746.4K<0.1%−41−2.2%ReducedHolders
Q4 20231,828$705.2K<0.1%+395+27.6%AddedHolders
Q3 20231,433$463.7K<0.1%+179+14.3%AddedHolders
Q2 20231,254$404.5K<0.1%+239+23.5%AddedHolders
Q1 20231,015$332.0K<0.1%+29+2.9%AddedHolders
Q4 2022986$338.6K<0.1%+94+10.5%AddedHolders
Q3 2022892$262.0K<0.1%+155+21.0%AddedHolders
Q2 2022737$218.0K<0.1%−40−5.1%ReducedHolders
Q1 2022777$257.0K<0.1%+1+0.1%AddedHolders
Q4 2021776$298.0K<0.1%+71+10.1%AddedHolders
Q3 2021705$266.0K<0.1%−16−2.2%ReducedHolders
Q2 2021721$274.0K<0.1%+12+1.7%AddedHolders
Q1 2021709$232.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.